Case study: Caring for expectant mothers with substance use disorder
With the country in the grips of an opioid epidemic, Norton Healthcare in 2015 launched the Maternal Opiate and Substance Treatment program, which makes it easy and non-stigmatizing for pregnant women with substance use disorder to access addiction treatment during obstetrical care, dramatically reducing admissions for neonatal abstinence syndrome. Read more.
Related News Articles
Headline
The U.S. birth rate declined by 1% in 2025, according to preliminary data released by the Centers for Disease Control and Prevention. The cesarean delivery…
Blog
h2, h3, h4 {color: #002855;}
Postpartum hemorrhage (PPH) is one of the most common — and preventable — causes of maternal health in the United States. The…
Headline
The cigarette smoking rate among U.S. adults dropped to 9.9% in 2024, the lowest level ever recorded, according to a report by the New England Journal of…
Headline
A study published by BMJ found that glucagon-like peptide-1 (GLP-1) drugs could help reduce the risk of various substance use disorders, including for alcohol…
Headline
The Substance Abuse and Mental Health Services Administration announced March 6 that it will award $69.1 million in grants for mental health and suicide…
Headline
The U.S. maternal mortality rate fell to 17.9 deaths per 100,000 live births in 2024, statistically similar to the 2023 rate of 18.6 per 100,000,…